Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Open. Closes February 8, 2028, 474 days from October 22, 2026, as posted on Grants.gov. Posted by Food and Drug Administration, opportunity number RFA-FD-25-017.
Get a first draft in your own AI assistant
Free, no account. Add CedarGrant to Claude, then paste this into a new chat. Your assistant reads the official notice, asks you a few questions and writes a first draft in the notice's format.
Use CedarGrant to help me apply for Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) (RFA-FD-25-017): https://simpler.grants.gov/opportunity/360007
Already writing? Paste this instead, with your draft attached:
Use CedarGrant to make a Requirements Map and run a Reviewer Panel on my draft for RFA-FD-25-017.
Notice facts
| Agency | Food and Drug Administration |
|---|---|
| Opportunity number | RFA-FD-25-017 |
| Assistance listing | 93.103 |
| Funding instrument | Grant |
| Category | Agriculture, Consumer Protection, Food and Nutrition |
| Posted | July 11, 2025 |
| Closes | February 8, 2028 |
| Award range | Up to $600,000 |
| Expected number of awards | Not stated |
| Total program funding | Not stated |
| Cost sharing or matching | Not required, per the notice |
| Applicant types listed | Others (see the notice's eligibility text) |
| Additional eligibility information | From the notice: Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationNonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)For-Profit OrganizationsSmall BusinessesFor-Profit Organizations (Other than Small Businesses)Local GovernmentsState… |
| Where to apply | Check the notice for where and how to submit. |
As posted on Grants.gov, checked October 21, 2026. CedarGrant lists what the notice states; it does not judge whether an organization is eligible. The official notice and its modifications control.
Summary from the notice
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
Official notice and documents
- No files are attached on Grants.gov. The full text is on the official page.
Similar open grants
| Closes | Grant | Agency | Award range |
|---|---|---|---|
| January 29, 2027 99 days left | Minor Use Minor Species Development of Drugs (R01) | Food and Drug Administration | Up to $250,000 |
| April 1, 2027 161 days left | Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed | Food and Drug Administration | Up to $300,000 |
| April 1, 2027 161 days left | NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens | Food and Drug Administration | Up to $200,000 |
| January 11, 2028 446 days left | Laboratory Flexible Funding Model (LFFM) | Food and Drug Administration | Up to $1,500,000 |
| May 12, 2028 568 days left | Animal and Veterinary Innovation Centers (U18) | Food and Drug Administration | Up to $1,250,000 |